Division of Gastrointestinal Surgery, Department of Surgery, Kyoto University Hospital, Kyoto, Japan.
Ann Surg. 2012 May;255(5):929-34. doi: 10.1097/SLA.0b013e31824a99e4.
To investigate the hypothesis that laparoscopic primary tumor resection is safe and effective when compared with the open approach for colorectal cancer patients with incurable metastases.
There are only a few reports with small numbers of patients on laparoscopic tumor resection for stage IV colorectal cancer.
Data from consecutive patients who underwent palliative primary tumor resection for stage IV colorectal cancer between January 2006 and December 2007 were collected retrospectively from 41 institutions. Short- and long-term outcomes were compared between patients who underwent laparoscopic or open resection.
A total of 904 patients (laparoscopic group: 226, open group: 678) with a median age of 64 years (range: 22-95) were included in the analysis. Conversion was required in 28 patients (12.4%) and the most common reasons for conversion (23/28: 82%) were bulky or invasive tumors. There was no 30-day postoperative mortality in either group. The complication rate (NCI-CTCAE grade 2-4) after laparoscopic surgery (17%) was significantly lower than that after open surgery (24%) (P = 0.02), and the difference was greater (4% vs 12%; P < 0.001) when we limited the analysis to severe (≥grade 3) complications. The median length of postoperative hospital stay in the laparoscopic group was significantly shorter than that in the open group (14 vs 17 days; P = 0.002). In univariate analysis, overall survival for the laparoscopic group was significantly better than that for open surgery (median survival time: 25.9 vs 22.3 months, P = 0.04), although no difference was apparent in multivariate analysis.
Compared with open surgery, laparoscopic primary tumor resection has advantages in the short term and no disadvantages in the long term. It is a reasonable treatment option for certain stage IV colorectal cancer patients with incurable disease.
研究假设腹腔镜原发肿瘤切除术与开放手术相比,在治疗无法治愈转移的结直肠癌患者时是安全且有效的。
仅有少数几篇报告涉及腹腔镜下 IV 期结直肠癌肿瘤切除术的小样本患者。
从 2006 年 1 月至 2007 年 12 月,连续从 41 家机构收集接受姑息性原发肿瘤切除术治疗 IV 期结直肠癌患者的数据。比较接受腹腔镜或开放切除术患者的短期和长期结果。
共纳入 904 例患者(腹腔镜组:226 例,开放组:678 例),中位年龄 64 岁(范围:22-95 岁)。28 例(12.4%)需要中转开腹,中转的最常见原因(23/28:82%)为肿瘤大或侵袭性。两组均无 30 天术后死亡病例。腹腔镜手术后(17%)的并发症发生率(NCI-CTCAE 分级 2-4)显著低于开放手术后(24%)(P = 0.02),当我们将分析仅限于严重(≥3 级)并发症时,差异更大(4%比 12%;P < 0.001)。腹腔镜组的术后中位住院时间明显短于开放组(14 比 17 天;P = 0.002)。单因素分析显示,腹腔镜组的总生存时间明显长于开放手术组(中位生存时间:25.9 比 22.3 个月,P = 0.04),尽管多因素分析未显示差异。
与开放手术相比,腹腔镜原发肿瘤切除术在短期内具有优势,而在长期内没有劣势。对于某些无法治愈的疾病的 IV 期结直肠癌患者,它是一种合理的治疗选择。